Autumn Rights Medical Guide 2019

OBSTRETICS
ASSISTED REPRODUCTIVE
TECHNOLOGY SURVEILLANCE
Edited by Dmitry M. Kissin
Centers for Disease Control and Prevention, Atlanta
G. David Adamson
Fertility Physicians of Northern California, Palo Alto
Georgina M. Chambers
National Perinatal Epidemiology and Statistics Unit, University of New South Wales, Sydney
and Christian De Geyter
University Hospital Basel
July 2019
246 x 189 mm 264pp
12 b/w illus. 12 colour
illus. 12 tables
978-1-108-49858-6 Hardback
£89.99
For over forty years, assisted reproductive technology (ART) has helped
millions of patients around the world to overcome infertility. Careful
monitoring of ART treatments and their outcomes is vital to maintain the
remarkable pace of change in science and technology, whilst minimizing
potential risks to infertility patients, and their children. Written by fortyfive
authors from twenty countries around the world, this book represents
a global effort to document the history of assisted reproductive technology
surveillance, and its dynamic challenges across the world. Comprehensive
in its approach, the text details best practices in collecting and using ART
surveillance data to monitor treatment effectiveness and safety, improve
quality of care, develop health policy, and provide accurate information to
infertility patients, worldwide.
WHY IT WILL SELL
• Provides a comprehensive,
detailed approach to best
practices in ART, by leading
experts
• Features sections on safe
monitoring of treatments,
improving quality of care and
developing health policies, across
continents
• Written by forty-five authors
from twenty countries around
the world, this book represents
a global effort to document the
forty-year history of assisted
reproductive technology
surveillance
CONTENTS
List of contributors; Foreword; Part I. Introduction to Assisted Reproductive Technology Surveillance:
1. Infertility and assisted reproductive technology; 2. Importance and history of assisted reproductive
technology surveillance; Part II. General Principles of Assisted Reproductive Technology Surveillance:
3. Assisted reproductive technology surveillance: who, what, when, and how?; 4. Future directions for
assisted reproductive technology surveillance and monitoring novel technology; Part III. Using Assisted
Reproductive Technology Surveillance Data: 5. Reporting assisted reproductive technology success
rates; 6. Using assisted reproductive technology surveillance data in clinical research; 7. Monitoring
assisted reproductive technology safety and biovigilance; 8. Quality assurance of assisted reproductive
technology practice: using data to improve clinical care; 9. Monitoring long-term outcomes of assisted
reproductive technology: linking surveillance data with other datasets; 10. Use of assisted reproductive
technology surveillance by infertility patients; Part IV. Global Variations in Assisted Reproductive Technology
Surveillance: 11. Global assisted reproductive technology surveillance: data from the international
committee monitoring ART (ICMART); 12. Global variations in assisted reproductive technology policy:
data from the international federation of fertility societies (IFFS); 13. ART surveillance in Africa; 14. ART
surveillance in Asia; 15. ART surveillance in Australia and New Zealand; 16. ART surveillance in Europe; 17.
ART surveillance in the Middle East; 18. ART surveillance in North America; 19. ART surveillance in Latin
America; Part V. Surveillance of Non-ART Fertility Treatments: 20. The role of non-IVF fertility treatments
in the management of infertility; 21. Non-ART surveillance; Appendix A. Assisted reproductive technology
surveillance system variables and definitions; Appendix B. International glossary on infertility and fertility
care; Appendix C. ICMART data collection form; Index.
ADDITIONAL INFORMATION
Level: medical specialists/consultants
www.cambridge.org/rights
foreignrights@cambridge.org
33
41583.indd 33 05/09/2019 10:12